Immunostimulation in the treatment of viral infection
Jonathan R. Waldstreicher, West Orange, NJ (US); William S. Krimsky, Forest Hill, MD (US); Robert E. Neal, II, Palo Alto, CA (US); Denise M. Zarins, Saratoga, CA (US); Robert J. Beetel, Sunnyvale, CA (US); Paul Brian Friedrichs, Belmont, CA (US); Kevin James Taylor, San Mateo, CA (US); and Roman Turovskiy, San Francisco, CA (US)
Assigned to Galvanize Therapeutics, Inc., Redwood City, CA (US)
Filed by Galvanize Therapeutics, Inc., Redwood City, CA (US)
Filed on Mar. 25, 2021, as Appl. No. 17/212,833.
Application 17/212,833 is a continuation in part of application No. 16/914,072, filed on Jun. 26, 2020, granted, now 11,471,208.
Application 16/914,072 is a continuation of application No. PCT/US2018/067501, filed on Dec. 26, 2018.
Application 17/212,833 is a continuation in part of application No. 16/227,796, filed on Dec. 20, 2018, granted, now 11,369,433.
Application 16/227,796 is a continuation of application No. PCT/US2017/039527, filed on Jun. 27, 2017.
Claims priority of provisional application 62/994,620, filed on Mar. 25, 2020.
Claims priority of provisional application 62/610,430, filed on Dec. 26, 2017.
Claims priority of provisional application 62/355,164, filed on Jun. 27, 2016.
Claims priority of provisional application 62/489,753, filed on Apr. 25, 2017.
Prior Publication US 2021/0236815 A1, Aug. 5, 2021
1. A method for treating a patient having an infection by a pathogen comprising:
positioning at least one electrode near a target tissue within the patient; and
delivering non-thermal pulsed electric field energy through at least one of the at least one electrode to the target tissue area so as to cause the infection to reduce, wherein the infection is reduced due to triggering of an immunostimulatory cascade within the patient that responds to the infection.
